" class="no-js "lang="en-US"> Claudine Bruck - Medtech Alert
Thursday, March 28, 2024
Claudine Bruck

Claudine Bruck

About Claudine Bruck

Claudine Bruck, Chairman and co-founder, has gathered 30 years of experience in drug and vaccine development across different therapeutic areas and technology platforms as a former GlaxoSmithKline Scientist and Executive. Her ambition is to apply her technical and business expertise to develop a transformational new medicine that will have a major impact on public health.

Related Story

Prolifagen Therapeutics Appoints M. Alexander Shaw, PhD, as Chief Executive Officer

September 14 2022

Prolifagen Therapeutics, a biotech startup developing medicines for cardiac regeneration, has appointed M. Alexander Shaw, PhD, […]